SE0000532D0 - New use - Google Patents

New use

Info

Publication number
SE0000532D0
SE0000532D0 SE0000532A SE0000532A SE0000532D0 SE 0000532 D0 SE0000532 D0 SE 0000532D0 SE 0000532 A SE0000532 A SE 0000532A SE 0000532 A SE0000532 A SE 0000532A SE 0000532 D0 SE0000532 D0 SE 0000532D0
Authority
SE
Sweden
Prior art keywords
neurotrophic
potentiating
differentiation
stem cell
combination
Prior art date
Application number
SE0000532A
Other languages
English (en)
Other versions
SE0000532L (sv
Inventor
Ted Ebendal
Original Assignee
Ted Ebendal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ted Ebendal filed Critical Ted Ebendal
Priority to SE0000532A priority Critical patent/SE0000532L/sv
Publication of SE0000532D0 publication Critical patent/SE0000532D0/sv
Priority to PCT/SE2001/000292 priority patent/WO2001060357A1/en
Priority to AU2001232578A priority patent/AU2001232578A1/en
Publication of SE0000532L publication Critical patent/SE0000532L/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/185Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0000532A 2000-02-18 2000-02-18 Ny användning SE0000532L (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0000532A SE0000532L (sv) 2000-02-18 2000-02-18 Ny användning
PCT/SE2001/000292 WO2001060357A1 (en) 2000-02-18 2001-02-14 New use
AU2001232578A AU2001232578A1 (en) 2000-02-18 2001-02-14 New use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0000532A SE0000532L (sv) 2000-02-18 2000-02-18 Ny användning

Publications (2)

Publication Number Publication Date
SE0000532D0 true SE0000532D0 (sv) 2000-02-18
SE0000532L SE0000532L (sv) 2001-08-19

Family

ID=20278500

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0000532A SE0000532L (sv) 2000-02-18 2000-02-18 Ny användning

Country Status (3)

Country Link
AU (1) AU2001232578A1 (sv)
SE (1) SE0000532L (sv)
WO (1) WO2001060357A1 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107485610B (zh) * 2016-06-12 2019-07-23 北京大学 咪康唑在预防血管破裂中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1511100A (en) * 1998-11-10 2000-05-29 Mcgill University Methods for identifying modulators of neuronal growth

Also Published As

Publication number Publication date
SE0000532L (sv) 2001-08-19
AU2001232578A1 (en) 2001-08-27
WO2001060357A1 (en) 2001-08-23

Similar Documents

Publication Publication Date Title
AR008853A1 (es) Nuevos compuestos farmaceuticamente activos, su uso en la fabricacion de medicamentos, metodo de tratamiento, composicion farmaceutica, compuestosintermediarios y proceso para la fabricacion de dichos compuestos
MY116651A (en) Topical ophthalmic formulations for treating allergic eye diseases
MX9403386A (es) Pirrolidin-3-il-alquilpiperidinas sustituidas.
EA200300248A1 (ru) Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции
BR0309278A (pt) Composto, composição, métodos para modular a atividade da cinesina ksp, para inibir a ksp, para o tratamento de uma doença proliferativa celular, e, uso de um composto
ECSP055809A (es) Inhibidores 4-oxo-1-(3-fenil sustituido)-1,4-dihidro-1,8-naftiridina-3-carboxamida de la fosfodiesterasa-4
BRPI0417820A (pt) heterociclos azabicìclicos como moduladores de receptor canabinóide
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
DK1159279T3 (da) 4-Oxo-4,7-dihydro-thieno[2,3-b]pyridin-5-carboxamider som antivirale midler
ATE230600T1 (de) Verwendung eines thienotriazoldiazepins zur erhöhung des apolopoproteins a-i niveaus
NO20052182L (no) Nye forbindelser
CA2174494A1 (en) Benzofurans
NZ335253A (en) certain [9-(cycloalkylmethyl or phenylmethyl)-5-carbamoyl-carbazol-4-yl]oxyacetic acid derivatives
ES2196331T3 (es) Derivados macrociclicos de cadena de 13 elementos de las eritromicinas a y b.
DE69628163D1 (de) Nor-pregnane zur induzierung hypothalamischer effekte
BR0213138A (pt) Métodos de tratar ou prevenir mal de alzheimer e uma doença distinguida por depósito de beta-amilóide no cérebro, de tratar um paciente que tenha, ou de prevenir um paciente de contrair uma doença ou condição, de produzir um complexo de beta-secretase e de inibir a produção de placa beta-amilóide em um animal, composição e uso de um composto
ES2160602T3 (es) Derivados de quinolona y acridinona para el tratamiento de la incontinencia urinaria.
DK0808303T3 (da) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyrederivater som tachykininreceptorantagonister
ES2163396T3 (es) Aminas biologicamente activas.
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
DE69420310T2 (de) Substituierte Pyrrole
ES2152379T3 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos.
ATE430575T1 (de) Laspartomycin-derivate, sowie ihre herstellung und verwendung
NO985676L (no) Forbindelser med colchicinstruktur, deres anvendelse som legemidler og blan
SE0000532D0 (sv) New use

Legal Events

Date Code Title Description
NAV Patent application has lapsed